News Research news

iLCT provides template for drug repurposing in other conditions

The International Linked Clinical Trials programme (iLCT) is one of the largest drug repurposing initiatives in medical research. A recent review article provides an overview of the history, structure and progress of this successful programme.

News Research news

Van Andel Institute: Virtual public lecture series

On 20 April, Van Andel Institute are holding a virtual webinar which will feature presentations and a Q&A session with international Parkinson’s disease experts including Cure Parkinson’s Drs. Richard Wyse and Simon Stott.

News Research news

A skin test for Parkinson’s

Researchers have been investigating a waxy substance on our skin (called sebum) as a possible way of determining who does or does not have Parkinson’s.

Results of the MOVES-PD trial announced

MOVES-PD is a global phase 2 study to assess the efficacy and safety of the drug venglustat in Parkinson’s patients who have a GBA-1 gene mutation. Sanofi designed the venglustat clinical trial to assess changes in the course of the disease.

News Research news

Further data on the relationship between diabetes and Parkinson’s

New research has found that there is convincing evidence that Type 2 diabetes is associated with a greater risk of Parkinson’s, but may in turn allow for better management of the disease.